Predictive Value of <i>SLCO1B1</i> c.521T>C Polymorphism on Observed Changes in the Treatment of 1136 Statin-Users

Predictive Value of <i>SLCO1B1</i> c.521T>C Polymorphism on Observed Changes in the Treatment of 1136 Statin-Users

Pharmacogenomic testing is a method to prevent adverse drug reactions. Pharmacogenomics could be relevant to optimize statin treatment, by identifying patients at high risk for adverse drug reactions. We aim to investigate the clinical validity and utility of pre-emptive pharmacogenomics screening i...

Full description

Bibliographic Details
Main Authors: Marleen E. Jansen, Tessel Rigter, Thom M. C. Fleur, Patrick C. Souverein, W. M. Monique Verschuren, Susanne J. Vijverberg, Jesse J. Swen, Wendy Rodenburg, Martina C. Cornel
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Genes
Subjects:
statins
pharmacogenomics
primary care
screening
adverse drug reactions
Online Access:https://www.mdpi.com/2073-4425/14/2/456

Internet

https://www.mdpi.com/2073-4425/14/2/456

Similar Items